Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 301.45
-1.25 (-0.41%)
At close: Mar 30, 2026
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 115.32 billion as of March 30, 2026. Its market cap has decreased by -61.15% in one year.
Market Cap
115.32B
Enterprise Value
117.20B
Revenue
10.79B
Ranking
n/a
PE Ratio
128.30
Stock Price
301.45
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 115.32B, an increase of 342,059.51%. That is a compound annual growth rate of 282.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 115.32B | -42.97% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 284.06B |
| Wockhardt | 193.28B |
| Piramal Pharma | 190.63B |
| Eris Lifesciences | 185.77B |
| NATCO Pharma | 175.29B |
| Alembic Pharmaceuticals | 132.40B |
| Alivus Life Sciences | 120.38B |
| Strides Pharma Science | 86.67B |